Stenger Family Office’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.81M Buy
15,021
+992
+7% +$231K 0.61% 48
2026
Q1
$3.43M Buy
14,029
+845
+6% +$197K 0.61% 44
2025
Q4
$2.73M Buy
13,184
+10,108
+329% +$2M 0.56% 45
2025
Q3
$585K Sell
3,076
-12,619
-80% -$2.16M 0.12% 79
2025
Q2
$2.63M Buy
+15,695
New +$2.41M 0.68% 41
2024
Q4
$2.16M Buy
+14,921
New +$2.31M 0.73% 33

Other funds holding JNJ

Stenger Family Office's JNJ Position: Q2 2026 in Review

Stenger Family Office increased its Johnson & Johnson (JNJ) stake by 7.1% in Q2 2026, buying an estimated $231K and bringing the position to 15,021 shares worth $3.81M. The position accounts for 0.61% of the portfolio, ranked #48.

Stenger Family Office first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stenger Family Office held 15,021 shares of Johnson & Johnson worth $3.81M as of Q2 2026.
  • Stenger Family Office bought 992 Johnson & Johnson shares in Q2 2026, an estimated $231K.
  • Johnson & Johnson made up 0.61% of Stenger Family Office's portfolio in Q2 2026, its #48 holding.
  • Stenger Family Office first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stenger Family Office's 13F filing for Q2 2026, filed 13 Jul 2026.